Detalhe da pesquisa
1.
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
Eur Heart J;
44(20): 1780-1794, 2023 05 21.
Artigo
em Inglês
| MEDLINE
| Mar 2023
| ID: mdl-36988155
2.
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv;
101(6): 1134-1143, 2023 05.
Artigo
em Inglês
| MEDLINE
| Abr 2023
| ID: mdl-37036268
3.
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
J Thromb Thrombolysis;
53(2): 380-389, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| 2022
| ID: mdl-34386899
4.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J;
42(45): 4624-4634, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| Out 2021
| ID: mdl-34662382
5.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J;
42(45): 4683-4693, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| Ago 2021
| ID: mdl-34423374
6.
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Catheter Cardiovasc Interv;
98(4): E494-E500, 2021 10.
Artigo
em Inglês
| MEDLINE
| Maio 2021
| ID: mdl-34032363
7.
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv;
98(6): E870-E880, 2021 11 15.
Artigo
em Inglês
| MEDLINE
| Abr 2021
| ID: mdl-33909348
8.
Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
Catheter Cardiovasc Interv;
98(2): 206-207, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| Ago 2021
| ID: mdl-34369065
9.
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
J Am Coll Cardiol;
82(2): 89-105, 2023 07 11.
Artigo
em Inglês
| MEDLINE
| Jul 2023
| ID: mdl-37407118
10.
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
Int J Cardiol;
383: 24-32, 2023 07 15.
Artigo
em Inglês
| MEDLINE
| Abr 2023
| ID: mdl-37080466
11.
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
JACC Cardiovasc Interv;
16(20): 2498-2510, 2023 10 23.
Artigo
em Inglês
| MEDLINE
| Out 2023
| ID: mdl-37804290
12.
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
JACC Cardiovasc Interv;
16(20): 2514-2524, 2023 10 23.
Artigo
em Inglês
| MEDLINE
| Out 2023
| ID: mdl-37879803
13.
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents.
Am J Cardiol;
167: 1-8, 2022 03 15.
Artigo
em Inglês
| MEDLINE
| Jan 2022
| ID: mdl-35031109
14.
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis.
ESC Heart Fail;
9(5): 3177-3187, 2022 10.
Artigo
em Inglês
| MEDLINE
| Jun 2022
| ID: mdl-35770326
15.
Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI.
Int J Cardiol;
364: 27-30, 2022 10 01.
Artigo
em Inglês
| MEDLINE
| Jun 2022
| ID: mdl-35716933
16.
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
EuroIntervention;
18(11): e897-e909, 2022 Dec 02.
Artigo
em Inglês
| MEDLINE
| Ago 2022
| ID: mdl-35979636
17.
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study.
EuroIntervention;
17(16): 1330-1339, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE
| 2022
| ID: mdl-34881696
18.
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.
JACC Cardiovasc Interv;
15(3): 282-293, 2022 02 14.
Artigo
em Inglês
| MEDLINE
| Jan 2022
| ID: mdl-35033468
19.
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.
JACC Cardiovasc Interv;
14(13): 1434-1446, 2021 07 12.
Artigo
em Inglês
| MEDLINE
| Jul 2021
| ID: mdl-34238553
20.
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.
JACC Cardiovasc Interv;
14(4): 444-456, 2021 02 22.
Artigo
em Inglês
| MEDLINE
| Fev 2021
| ID: mdl-33602441
Resultados
1 -
20
de 26